ABDX logo

Abingdon Health Plc Stock Price

AIM:ABDX Community·UK£41.2m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ABDX Share Price Performance

UK£0
-0.06 (-100.00%)
UK£0.19
Fair Value
UK£0
-0.06 (-100.00%)
Price UK£0

ABDX Community Narratives

·
Fair Value UK£0.19 50.0% undervalued intrinsic discount

Lateral Flow Adoption And Digital Diagnostics Will Support A Stronger Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

Updated Narratives

ABDX logo

Lateral Flow Adoption And Digital Diagnostics Will Support A Stronger Long Term Outlook

Fair Value: UK£0.19 50.0% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with excellent balance sheet.

2 Risks
1 Reward

Abingdon Health Plc Key Details

UK£9.6m

Revenue

UK£5.6m

Cost of Revenue

UK£4.0m

Gross Profit

UK£7.2m

Other Expenses

-UK£3.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.0075
41.38%
-33.88%
11.9%
View Full Analysis

About ABDX

Founded
2008
Employees
129
CEO
n/a
WebsiteView website
www.abingdonhealth.com

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.